{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:46:08Z","timestamp":1782470768249,"version":"3.54.5"},"reference-count":90,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,26]],"date-time":"2027-06-26T00:00:00Z","timestamp":1813968000000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WU23GE0"],"award-info":[{"award-number":["WU23GE0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HARIND23GE0"],"award-info":[{"award-number":["HARIND23GE0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["RUNCHE25GE0"],"award-info":[{"award-number":["RUNCHE25GE0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eprac.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:57:59Z","timestamp":1774425479000},"page":"1139-1146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Updates in Cystic Fibrosis Bone Disease in Adults"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7789-6055","authenticated-orcid":false,"given":"Shauna","family":"Runchey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasma","family":"Harindhanavudhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malinda","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.03.004_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1055\/s-0039-1697917","article-title":"Endocrine complications of cystic fibrosis: a multisystem disease of the endocrine organs","volume":"40","author":"Ode","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chest.2022.07.004","article-title":"The changing epidemiology of cystic fibrosis: the implications for adult care","volume":"163","author":"Burgel","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.eprac.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/jbmr\/zjae139","article-title":"Longitudinal changes in BMD in adults with cystic fibrosis","volume":"39","author":"Jad","year":"2024","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.eprac.2026.03.004_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2023.02.004","article-title":"Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del","volume":"22","author":"Lopez","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcf.2015.01.011","article-title":"Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period","volume":"14","author":"Putman","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2474-9-125","article-title":"Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients","volume":"9","author":"Papaioannou","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.eprac.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-128-3-199802010-00004","article-title":"Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis","volume":"128","author":"Aris","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10666","article-title":"Prevalence and risk factors for low bone mineral density in adults with cystic fibrosis","volume":"6","author":"Boyle","year":"2022","journal-title":"JBMR Plus"},{"key":"10.1016\/j.eprac.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcf.2009.11.005","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone","volume":"9","author":"Le Heron","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.3390\/jcm14165657","article-title":"Bone disease in cystic fibrosis: insights into etiopathogenesis and advances in treatment management","volume":"14","author":"Giordano","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/20420188251328210","article-title":"Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment","volume":"16","author":"Cobb","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.03.004_bib15","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1164\/rccm.202012-4434ED","article-title":"Where is the cystic fibrosis transmembrane conductance regulator?","volume":"203","author":"Barbry","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1085\/jgp.200810122","article-title":"CFTR functions as a bicarbonate channel in pancreatic duct cells","volume":"133","author":"Ishiguro","year":"2009","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.eprac.2026.03.004_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thx.2006.075887","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone","volume":"62","author":"Shead","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.eprac.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcf.2025.01.005","article-title":"CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis","volume":"24","author":"Dumortier","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/09031936.04.00050204","article-title":"Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor","volume":"25","author":"King","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eprac.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.4753","article-title":"Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis","volume":"240","author":"Delion","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.eprac.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcf.2022.08.011","article-title":"Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosis","volume":"22","author":"Abid","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib22","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1164\/rccm.200206-578OC","article-title":"Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis","volume":"166","author":"Elkin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib23","article-title":"Bone accrual and structural changes over one year in youth with cystic fibrosis","volume":"28","author":"Bass","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.eprac.2026.03.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116835","article-title":"Changes in bone turnover after high-dose vitamin D supplementation during acute pulmonary exacerbation in cystic fibrosis","volume":"174","author":"Wu","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.eprac.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.eprac.2026.03.004_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0002-9343(77)90290-X","article-title":"Rickets in adult cystic fibrosis with myopathy, pancreatic insufficiency and proximal renal tubular dysfunction","volume":"63","author":"Scott","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","article-title":"An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the cystic fibrosis foundation","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.03.004_bib28","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1210\/jc.2003-031879","article-title":"Calcium kinetics are altered in clinically stable girls with cystic fibrosis","volume":"89","author":"Schulze","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2015.09.013","article-title":"Treatment of vitamin D deficiency in cystic fibrosis","volume":"164","author":"Chesdachai","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.eprac.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1590\/bjpt-rbf.2014.0154","article-title":"The role of daily physical activity and nutritional status on bone turnover in cystic fibrosis: a cross-sectional study","volume":"20","author":"Tejero","year":"2016","journal-title":"Braz J Phys Ther"},{"key":"10.1016\/j.eprac.2026.03.004_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1378\/chest.10-1508","article-title":"Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis","volume":"140","author":"Tejero Garc\u00eda","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.eprac.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archpedi.1981.02130290020009","article-title":"The reproductive endocrine system in cystic fibrosis. I. Basal gonadotropin and sex steroid levels","volume":"135","author":"Reiter","year":"1981","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.eprac.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bone.2004.05.009","article-title":"Prevalence and correlates of vertebral fractures in adults with cystic fibrosis","volume":"35","author":"Rossini","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.eprac.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.amjms.2024.07.013","article-title":"Testosterone concentrations and associated predictors in men with cystic fibrosis: a retrospective, single-center study","volume":"368","author":"Jathal","year":"2024","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.eprac.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/GME.0000000000002155","article-title":"Menopause in people with cystic fibrosis","volume":"30","author":"Prochownik","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.eprac.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.eprac.2025.04.011","article-title":"Menopause in cystic fibrosis: special considerations for bone health, menopausal symptoms, and treatment","volume":"31","author":"Haroon","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/bjsports-2018-099723","article-title":"Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial","volume":"53","author":"Ackerman","year":"2019","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib39","article-title":"Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density","volume":"20","author":"Wu","year":"2020","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.eprac.2026.03.004_bib40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjms.2020.06.005","article-title":"Relationship between estrogen treatment and skeletal health in women with cystic fibrosis","volume":"360","author":"Wu","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.eprac.2026.03.004_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","article-title":"Glucocorticoid-induced osteoporosis and osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.eprac.2026.03.004_bib42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2019-000569","article-title":"Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children","volume":"3","author":"Ahmet","year":"2019","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.eprac.2026.03.004_bib44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.eprac.2026.03.004_bib45","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","article-title":"Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men","volume":"167","author":"Haney","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib46","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/ejendo\/lvaf182","article-title":"Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients","volume":"193","author":"Diker Cohen","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.03.004_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/thx.2005.046516","article-title":"Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis","volume":"61","author":"Buntain","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.eprac.2026.03.004_bib48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/thx.54.11.961","article-title":"Low bone mineral density in adults with cystic fibrosis","volume":"54","author":"Haworth","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.eprac.2026.03.004_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.eprac.2026.03.004_bib50","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2026.03.004_bib51","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.eprac.2026.03.004_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00467-009-1249-z","article-title":"Official positions of the International society for clinical densitometry (ISCD) on DXA evaluation in children and adolescents","volume":"25","author":"Bianchi","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.eprac.2026.03.004_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2023.101437","article-title":"DXA reporting updates: 2023 official positions of the international society for clinical densitometry","volume":"27","author":"Krueger","year":"2024","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.eprac.2026.03.004_bib55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00198-021-06290-x","article-title":"Trabecular bone score in people with cystic fibrosis","volume":"33","author":"Anabtawi","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.eprac.2026.03.004_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bone.2016.04.030","article-title":"Trabecular and cortical bone deficits are present in children and adolescents with cystic fibrosis","volume":"90","author":"Kelly","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.eprac.2026.03.004_bib57","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00198-016-3557-z","article-title":"Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis","volume":"27","author":"Putman","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.eprac.2026.03.004_bib58","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2014-1982","article-title":"Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis","volume":"99","author":"Putman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.03.004_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/eje.0.1460531","article-title":"Bone mineral density and quantitative ultrasound in adults with cystic fibrosis","volume":"146","author":"Flohr","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.03.004_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2011.10.004","article-title":"Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis","volume":"11","author":"De Schepper","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib61","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.3390\/jcm13195961","article-title":"Opportunistic screening for low bone mineral density in adults with cystic fibrosis using low-dose computed tomography of the chest with artificial intelligence","volume":"13","author":"Welsner","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11657-025-01578-5","article-title":"Opportunistic assessment of bone mineral density in cystic fibrosis patients using ultra-low dose thoracic CT","volume":"20","author":"Shet","year":"2025","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.eprac.2026.03.004_bib63","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2265.2008.03216.x","article-title":"Vitamin D and bone health in adults with cystic fibrosis","volume":"69","author":"Wolfenden","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2026.03.004_bib64","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ecl.2020.07.005","article-title":"Advances in the bone health assessment of children","volume":"49","author":"Ward","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.eprac.2026.03.004_bib65","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1210\/clinem\/dgaa890","article-title":"The effects of ivacaftor on bone density and microarchitecture in children and adults with cystic fibrosis","volume":"106","author":"Putman","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.03.004_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71280","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor effect on bone density and body composition: a retrospective analysis","volume":"60","author":"Trost","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.eprac.2026.03.004_bib67","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/AOG.0000000000004730","article-title":"Management of postmenopausal osteoporosis: ACOG clinical practice guideline no. 2","volume":"139","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eprac.2026.03.004_bib68","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.2022.18625","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal persons: US preventive services task force recommendation statement","volume":"328","author":"Mangione","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.eprac.2026.03.004_bib69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-2600(13)70064-X","article-title":"Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate","volume":"1","author":"Bianchi","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib70","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.08-0608","article-title":"Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial)","volume":"134","author":"Papaioannou","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.eprac.2026.03.004_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.200307-1049OC","article-title":"Efficacy of alendronate in adults with cystic fibrosis with low bone density","volume":"169","author":"Aris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib72","first-page":"270","article-title":"Oral bisphosphonates improve bone mineral density in adults with cystic fibrosis","volume":"98","author":"Cawood","year":"2005","journal-title":"Ir Med J"},{"key":"10.1016\/j.eprac.2026.03.004_bib73","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jcf.2011.07.007","article-title":"Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis","volume":"10","author":"Haworth","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib74","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1164\/ajrccm.162.3.2002051","article-title":"Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation","volume":"162","author":"Aris","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eprac.2026.03.004_bib75","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/thorax.56.4.314","article-title":"Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis","volume":"56","author":"Haworth","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.eprac.2026.03.004_bib76","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2265.2008.03434.x","article-title":"Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)","volume":"70","author":"Chapman","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2026.03.004_bib77","article-title":"Evaluation of teriparatide for treatment of osteoporosis in four patients with cystic fibrosis: a case series","volume":"2014","author":"Siwamogsatham","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.eprac.2026.03.004_bib78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjms.2022.04.018","article-title":"Romosozumab used to treat a patient with cystic fibrosis-related osteoporosis","volume":"364","author":"Crow","year":"2022","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.eprac.2026.03.004_bib79","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"1","author":"Jeffery","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eprac.2026.03.004_bib80","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.eprac.2026.03.004_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s42000-023-00521-y","article-title":"\u03a4he story of sclerostin inhibition: the past, the present, and the future","volume":"24","author":"Anastasilakis","year":"2025","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.eprac.2026.03.004_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.03.004_bib83","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement","volume":"319","author":"Curry","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.eprac.2026.03.004_bib84","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society\u2217 Clinical Practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.03.004_bib85","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update","volume":"105","author":"Shoback","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.03.004_bib86","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ppul.26970","article-title":"SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; proceedings of the International shaping initiatives and future trends (SHIFT) symposium","volume":"59","author":"O'Donnell","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.eprac.2026.03.004_bib87","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","article-title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","volume":"23","author":"Burgel","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib88","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcf.2022.01.011","article-title":"Bone mineral density screening by DXA for people with cystic fibrosis: a registry analysis of patient and program factors influencing rates of screening","volume":"21","author":"Ratti","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2026.03.004_bib89","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jcf.2019.08.018","article-title":"Cystic fibrosis bone disease: pathophysiology, assessment and prognostic implications","volume":"18","author":"Anabtawi","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.03.004_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149257","article-title":"Unlocking the potential of CRISPR-Cas9 for cystic fibrosis: a systematic literature review","volume":"942","author":"Harris","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.eprac.2026.03.004_bib91","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/MCP.0000000000000479","article-title":"Disease-modifying genetic factors in cystic fibrosis","volume":"24","author":"Marson","year":"2018","journal-title":"Curr Opin Pulm Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26008232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26008232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:48:29Z","timestamp":1782467309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26008232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":90,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1530891X26008232"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.03.004","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in Cystic Fibrosis Bone Disease in Adults","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}